Related Experiment Video

Updated: Aug 29, 2026

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury

Osama N El-Assal1, Gail E Besner

  • 1Department of Surgery, Children's Hospital and The Ohio State University College of Medicine and Public Health, Columbus, OH 43205, USA.

Seminars in Pediatric Surgery
|February 7, 2004
PubMed

Insights

Heparin-binding epidermal growth factor-like factor (HB-EGF) shows promise for treating intestinal ischemia/reperfusion (I/R) injury. This factor aids tissue repair and survival, offering a potential therapy for conditions like necrotizing enterocolitis.

Area of Science:

  • Gastroenterology and Regenerative Medicine
  • Molecular Biology and Cell Signaling

Background:

  • Intestinal ischemia/reperfusion (I/R) injury poses significant risks, particularly for vulnerable populations like premature infants and the elderly.
  • Current treatments for severe gut ischemia often involve extensive resection, leading to long-term complications such as growth retardation and nutritional deficiencies.
  • Loss of intestinal barrier and immune functions, along with secondary organ damage, contributes to the poor outcomes associated with intestinal I/R.

Purpose of the Study:

  • To review and summarize the therapeutic potential of heparin-binding epidermal growth factor-like factor (HB-EGF) in mitigating intestinal I/R injury.
  • To explore the underlying mechanisms by which HB-EGF exerts its protective effects in the context of intestinal I/R.

Main Methods:

  • Review of existing research and experimental findings on HB-EGF's role in intestinal I/R.
  • Analysis of HB-EGF's known functions, including mitogenic, chemoattractant, and anti-apoptotic properties.
  • Examination of HB-EGF's involvement in wound healing and postischemic regeneration across various organs.

Main Results:

  • HB-EGF demonstrates significant beneficial effects in preclinical models of intestinal I/R.
  • Its potent anti-apoptotic activity helps cells and tissues survive hypoxic, oxidative, and nutritional stresses.
  • HB-EGF promotes postischemic regeneration and wound healing in the intestine.

Conclusions:

  • The collective evidence strongly supports a therapeutic role for HB-EGF in managing intestinal ischemic diseases.
  • HB-EGF represents a promising therapeutic agent for conditions such as intestinal I/R and necrotizing enterocolitis.
  • Further investigation into HB-EGF mechanisms could lead to novel treatment strategies for gut ischemia.

More Related Videos

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy07:05

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy

Published on: September 27, 2024

Related Concept Videos

Healing I: Introduction01:11

Healing I: Introduction

Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...